FONR · As filed with the SEC
Fonar income statement, by quarter
The statement as Fonar presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | Q3 FY26 3 months ended Mar 31, 2026 | Q2 FY26 3 months ended Dec 31, 2025 | Q1 FY25 3 months ended Sep 30, 2025 | Q4 FY25† 3 months ended Jun 30, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Patient fee revenue – net of contractual allowances and discounts | 8,085 | 7,296 | 7,572 | 8,895.45† |
| Product sales | 75 | 126 | 316 | 363.30† |
| Service and repair fees | 2,162 | 2,195 | 2,182 | 2,187.05† |
| Service and repair fees – related parties | 45 | 45 | 45 | 45† |
| Management and other fees | 13,118 | 12,897 | 12,941 | 12,453.56† |
| Management and other fees – related medical practices | 2,987 | 2,988 | 2,987 | 3,331.97† |
| Total Revenues – Net | 26,472 | 25,547 | 26,043 | 27,276.32† |
| Cost and Expenses | ||||
| Cost of Revenue | 4,781 | 5,014 | 4,929 | 4,960.94† |
| Costs related to product sales | 277 | 215 | 324 | 257.03† |
| Costs related to service and repair fees | 1,163 | 1,212 | 1,059 | 1,297.52† |
| Costs related to service and repair fees – related parties | 7 | 11 | 8 | 169.50† |
| Costs related to management and other fees | 7,431 | 7,858 | 7,812 | 8,065.05† |
| Costs related to management and other fees – related medical practices | 1,572 | 1,543 | 1,464 | 1,500.28† |
| Research and Development Expense | 424 | 455 | 440 | 452.09† |
| Selling, General and Administrative Expense | 8,373 | 6,239 | 6,813 | 9,679.16† |
| Total Costs and Expenses | 24,028 | 22,547 | 22,849 | 26,381.56† |
| Income from Operations | 2,444 | 3,000 | 3,194 | 894.76† |
| Interest expense | (3) | (4) | (1) | (4.61)† |
| Interest income – related party | 12 | 12 | 12 | 12.92† |
| Non-Operating Income (Expense) | 363 | 431 | 474 | 492.98† |
| Non-Operating Income (Expense) | 4 | 3 | 3 | 37.20† |
| Income Before Provision for Income Taxes and Noncontrolling Interests | 2,820 | 3,442 | 3,682 | 1,433.24† |
| Provision for income taxes | (492) | (903) | (1,012) | (88.81)† |
| Consolidated Net Income | — | 2,539 | 2,670 | — |
| Net Income – Noncontrolling Interests | — | (483) | — | — |
| Net Income – Attributable to FONAR | — | 2,056 | — | — |
| Consolidated Net Income | 2,328 | — | — | 1,344.43† |
| Net Income – Noncontrolling Interests | (687) | — | (406) | (615.17)† |
| Net Income – Attributable to FONAR | 1,641 | — | 2,264 | 729.26† |
| Common Stockholders | 1,537 | 1,924 | 2,120 | 680.35† |
| Class A Non Voting Preferred Stockholders | 78 | 98 | 108 | 36.44† |
| Common Class C | 26 | 34 | 36 | 12.47† |
| Common Stockholders | 0.25 | 0.31 | 0.34 | — |
| Common Class C | 0.07 | 0.09 | 0.10 | — |
| Common Stockholders | 0.24 | 0.31 | 0.34 | — |
| Common Class C | 0.07 | 0.09 | 0.10 | — |
| Weighted Average Shares Outstanding | 6,865 | 6,865 | 6,865 | — |
| Common Stockholders | 6,169 | 6,169 | 6,169 | — |
| Common Class C | 383 | 383 | 383 | — |
| Common Stockholders | 6,296 | 6,296 | 6,296 | — |
| Common Class C | 383 | 383 | 383 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.